Results 171 to 180 of about 168,140 (338)

Brief report: Four-year survival with durvalumab after chemoradiotherapy in Stage III NSCLC - an update from the PACIFIC trial.

Journal of Thoracic Oncology, 2020
C. Faivre-Finn, D. Vicente, T. Kurata, D. Planchard, L. Paz-Ares, J. Vansteenkiste, D. Spigel, M. Garassino, M. Reck, S. Senan, J. Naidoo, A. Rimner, Yi-long Wu, J. Gray, M. Özgüroğlu, K. Lee, B. Cho, T. Kato, M. de Wit, M. Newton, Lu Wang, P. Thiyagarajah, S. Antonia   +22 more
semanticscholar   +1 more source

Pretreatment Neutrophil‐to‐Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study

Head &Neck, EarlyView.
ABSTRACT Background Pretreatment neutrophil to lymphocyte ratio (NLR) is a negative prognostic marker for survival in head and neck cancer (HNC). Its association with treatment toxicity and intolerance in patients undergoing curative‐intent surgery is unknown. Methods Ambispective study of patients with operable stage II–IV, HPV‐negative HNC treated at
Raisa Chowdhury, Karim Botros, Keith Richardson, Alex M. Mlynarek, Nader Sadeghi, Michael P. Hier, Sabrina Wurzba, Khashayar Esfahani, Nathaniel Bouganim, Khalil Sultanem, George Shenouda, Christina Tsien, Marco A. Mascarella   +12 more
wiley   +1 more source

Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population‐based study in the Netherlands

International Journal of Cancer, EarlyView.
What's New? A range of treatment options exist for metastatic esophageal (EC) and gastric cancer (GC). Which modalities or combination thereof are optimal for these malignancies, however, remains uncertain. Here, the authors examined differences in systemic treatment for metastatic EC and GC across hospitals in the Netherlands.
Julie F. M. Geerts, Pauline A. J. Vissers, Bianca Mostert, Bas P. L. Wijnhoven, Brigitte C. M. Haberkorn, Marie‐Paule G. F. Anten, Camiel Rosman, Geert‐Jan Creemers, Harm Westdorp, Maurice J. C. van der Sangen, Rob H. A. Verhoeven, Grard A. P. Nieuwenhuijzen   +11 more
wiley   +1 more source

Preventive Effect of Rebamipide Gargle on Chemoradiotherpy-Induced Oral Mucositis in Patients with Oral Cancer: a Pilot Study

eJournal of Oral Maxillofacial Research, 2011
Objectives: To assess the efficacy and safety of rebamipide in preventing chemoradiotherapy-induced oral mucositis in patients with oral cancer.Material and Methods: Patients with oral cancer treated with chemoradiotherapy (daily radiotherapy plus ...
Takashi Yasuda, Hiroshige Chiba, Takafumi Satomi, Akira Matsuo, Tadayoshi Kaneko, Daichi Chikazu, Hironobu Miyamatsu   +6 more
doaj  

Self-expandable Metallic Stents for Patients with Recurrent Esophageal Carcinoma After Failure of Primary Chemoradiotherapy [PDF]

, 2001
Manabu Muto, Atsushi Ohtsu, Yoshinori Miyata, Yasukazu Shioyama, Narikazu Boku, Shigeo Yoshida   +5 more
openalex   +1 more source

Real‐world study on fluoropyrimidine‐related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype‐guided dosing

International Journal of Cancer, EarlyView.
What's New? Fluoropyrimidines, a key component of chemotherapy regimens for a variety of solid tumors, can cause severe toxicity. Patients who have specific genetic variants in the DPYD gene, which encodes an enzyme that inactivates fluoropyrimidines, have increased susceptibility to this toxicity.
Sofía L. J. Peeters, Didier Meulendijks, Zerina Kadric, Sara Ibrovic, Geert‐Jan Creemers, Vanja Milosevic, Matthijs van de Poll, Lieke H. J. Simkens, Birgit A. L. M. Deiman, Hans Gelderblom, Henk‐Jan Guchelaar, Anna M. J. Thijs, Maarten J. Deenen   +12 more
wiley   +1 more source

Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy [PDF]

, 2001
Katsutoshi Miura, Hiroyuki Mineta, Naoki Yokota, Yoshihiro Tsutsui   +3 more
openalex   +1 more source

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cancer

International Journal of Cancer, EarlyView.
What's New? This study introduces a novel approach for detecting locally advanced esophageal carcinoma using cell‐free DNA (cfDNA) analysis through a highly sensitive fragmentome assay. Unlike traditional sequencing‐based methods that are limited by the absence of specific mutations in esophageal tumors, our method offers an alternative by quantifying ...
Anouchka Modesto, Sophie Gibert, Caroline Delmas, David Tougeron, Amaury Paumier, Alexandre Taillez, Samuel Le Sourd, Delphine Argo Leignel, Philippe Ronchin, Ariane Darut Jouve, Véronique Vendrely, Olivier Riou, Jérôme Martin‐Babau, Thomas Leroy, Laurent Quéro, Naïma Hanoun, Pierre Cordelier, Veronica Pezzella, Jean Pierre Delord, Rosine Guimbaud, Elizabeth Moyal, Catherine Seva   +21 more
wiley   +1 more source

Definitive chemoradiotherapy with Carboplatin Plus Paclitaxel for Unresectable Locally Advanced Thymic Carcinoma: A case series

Current Problems in Cancer: Case Reports
Objectives: Thymic carcinoma (TC) is rare. There is no evidence regarding the treatment strategies for unresectable locally advanced thymic carcinomas. Definitive chemoradiotherapy may treat this condition. However, an appropriate concurrent chemotherapy
Koichiro Nozaki, Satoshi Watanabe, Ryo Yamazaki, Masashi Arita, Toshiaki Kikuchi   +4 more
doaj  

Life threatening laryngeal toxicity following treatment with combined chemoradiotherapy for nasopharyngeal cancer: A case report with review of the literature

, 1999
Sally Baron‐Hay, Anthony Clifford, Michael Jackson, Sharon E. Clarke   +3 more
openalex   +1 more source